A Study of AMG 193 in Subjects With Advanced MTAP-null Solid Tumors

A Study of AMG 193 in Subjects With Advanced MTAP-null Solid Tumors
Conditions: Advanced MTAP-null Solid Tumors

Interventions: Drug: AMG 193; Drug: Docetaxel; Drug: Comparator AMG 193 Test Tablet

Sponsors: Amgen

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 2, 2024Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments